This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_MULTIPLE_MYELOMA_PLASMA_CELL_EXALLC for full statistics.
This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_MULTIPLE_MYELOMA_PLASMA_CELL_EXALLC for full statistics.
CD2_MULTIPLE_MYELOMA_PLASMA_CELL
multiple myeloma: A bone marrow-based plasma cell neoplasm characterized by a serum monoclonal protein and skeletal destruction with osteolytic lesions, pathological fractures, bone pain, hypercalcemia, and anemia. Clinical variants include non-secretory myeloma, smoldering myeloma, indolent myeloma, and plasma cell leukemia. (WHO, 2001)
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
429209 |
1. Apply sex-specific ruleNone |
429209 |
2. Check conditionsNone |
429209 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1394 |
4. Check minimum number of eventsNone |
1394 |
5. Include endpointsNone |
1394 |
6. Filter based on genotype QC (FinnGen only) |
1337 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
List of similar endpoints to Multiple myeloma and malignant plasma cell neoplasms based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
All | Female | Male | |
---|---|---|---|
Number of individuals | 1337 | 583 | 754 |
Unadjusted period prevalence (%) | 0.34 | 0.25 | 0.41 |
Median age at first event (years) | 68.79 | 67.66 | 69.67 |
Not a core endpoint, no data to show.
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Index endpoint: CD2_MULTIPLE_MYELOMA_PLASMA_CELL – Multiple myeloma and malignant plasma cell neoplasms
GWS hits: -
Loading Relationships table